30
Participants
Start Date
April 1, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
January 31, 2026
Fecal Microbiota Transplant (FMT) oral capsules
Donors will be healthy individuals, selected through a previously published, rigorous screening process. Elizabeth Hohmann M.D. of MGH has demonstrated the safety and therapeutic efficacy of oral frozen FMT capsules in Clostridium difficile infection, and her lab will produce the capsules for this study.
Placebo oral capsule
Oral placebo capsules filled with glycerol and cocoa powder. These capsules are identical in appearance to FMT capsules.
Massachusetts General Hospital, Boston
Center for Microbiome Informatics and Therapeutics
UNKNOWN
Massachusetts General Hospital
OTHER